WTO’s DG Okonjo-Iweala Welcomes New US Support For Waiver On COVID Vaccine IP: ‘We Need To Respond Urgently’ 06/05/2021 Chandre Prince, Raisa Santos & Elaine Ruth Fletcher World Trade Organization’s (WTO) director general Ngozi Onkonjo-Iweala on Thursday hailed the United States government’s decision to support the suspension of intellectual property rules on COVID-19 vaccines – while also emphasising the urgency of even more immediate actions to increase vaccine supplies to lower-income countries. In a statement after a two-day closed-door WTO General […] Continue reading -> BREAKING – US Swings Weight Behind Global IP Waiver On COVID Vaccines; WTO Inches Towards ‘Text-Based’ Negotiations 05/05/2021 Elaine Ruth Fletcher The United States has swung its weight behind a hotly-debated proposal by India and South Africa to suspend intellectual property rights on COVID-19 vaccines for the duration of the pandemic. The dramatic turnabout in the US position, announced Wednesday evening by US Trade Representative Katherine Tai, signals a sea change in the balance of powers […] Continue reading -> Time to End ‘Delaying Tactics’ on TRIPS Waiver, Say India And South Africa Ahead Of Critical WTO Meeting 04/05/2021 Kerry Cullinan CAPE TOWN – The “circular discussion” at the World Trade Organization (WTO) on the TRIPS waiver needs to move to “text-based” negotiations, Ambassador Xolelwa Mlumbi-Peter, South Africa’s Permanent Representative to the WTO said on Tuesday. Her Indian counterpart, Brajendra Navnit, added that opponents of the waiver had been using “delaying tactics” since the beginning of […] Continue reading -> The ‘Silent Pandemic’ of Antimicrobial Resistance – Lessons Learned From COVID-19 30/04/2021 Raisa Santos In the midst of the COVID-19 pandemic, a “silent pandemic” of drug resistance to mutated bacteria, viruses and parasites is gaining ground and requires major government investments in antibiotic research and development (R&D), a group of experts has warned. “People are dying across the world from drug-resistant infections. This is a problem of today, and […] Continue reading -> New Wave Of Appeals For WTO Waiver On IP For COVID Treatments Ahead of TRIPS Council Meeting 27/04/2021 Elaine Ruth Fletcher Nearly 400 members of the European Parliament (MEPs) and of national parliaments from across the European Union issued a joint appeal Tuesday calling for the European Commission to drop its opposition to a proposed WTO waiver on IP related to COVID-19 health technologies for the duration of the pandemic, being co-sponsored by India and South […] Continue reading -> Pharmaceutical Industry Launches Document on IP Principles Amid Push for TRIPS Waiver 26/04/2021 Kerry Cullinan Amid a huge global push for the World Trade Organization (WTO) to waive intellectual property (IP) rights on products related to COVID-19 for the duration of the pandemic, the pharmaceutical industry launched a document on Monday – World IP Day – asserting that a “strong IP system advances public health” . According to the 10-point […] Continue reading -> The ‘Patent Bargain’, Public Good & COVID19 26/04/2021 Priti Patniak/Geneva Health Files As the hotly contested proposal for an IP waiver on COVID-related health products comes up again for debate on Friday, 30 April at the World Trade Organization’s TRIPS Council, legal expert Hyo Yoon Kang looks at the foundations of IP law to challenge “TRIPS waiver” naysayers. Geneva Health Files [GHF]: You have argued that IP […] Continue reading -> ACT-Accelerator Celebrates 1st Anniversary Amid COVID-19 Surge in India 23/04/2021 Kerry Cullinan One of the few silver linings of the COVID-19 pandemic is the unprecedented collaboration of every sector of society to overcome it – best demonstrated by the Access to COVID-19 Tools Accelerator (ACT-Accelerator), which celebrated its first anniversary on Friday. The ACT-Accelerator’s most famous pillar is the vaccine facility, COVAX, which has distributed almost 40 […] Continue reading -> Growing Consensus Emerging At WTO – Strengthen Supply Chain & Tech Transfer To Expand Vaccine Access 15/04/2021 Svĕt Lustig Vijay A growing consensus seems to be emerging out of this week’s high-level WTO meeting that glaring inequities in access to vaccines can be remedied by strengthening supply chains, avoiding export bans across borders, and ensuring that big pharma voluntarily transfers its vaccine technologies to poorer countries so they can produce their own vaccines. “The significant […] Continue reading -> ‘Unexamined Prejudices’: COVID-19 And Patents 15/04/2021 Sir Robin Jacob This past few weeks has seen a flurry of open letters from academics, politicians and NGOs dispatched to British Prime Minister Boris Johnson, US President Joe Biden and other heads of state, urging their governments to support a proposal to the World Trade Organization to for a proposed “waiver” suspending intellectual property (IP) rights, and […] Continue reading -> Posts navigation Older postsNewer posts
BREAKING – US Swings Weight Behind Global IP Waiver On COVID Vaccines; WTO Inches Towards ‘Text-Based’ Negotiations 05/05/2021 Elaine Ruth Fletcher The United States has swung its weight behind a hotly-debated proposal by India and South Africa to suspend intellectual property rights on COVID-19 vaccines for the duration of the pandemic. The dramatic turnabout in the US position, announced Wednesday evening by US Trade Representative Katherine Tai, signals a sea change in the balance of powers […] Continue reading -> Time to End ‘Delaying Tactics’ on TRIPS Waiver, Say India And South Africa Ahead Of Critical WTO Meeting 04/05/2021 Kerry Cullinan CAPE TOWN – The “circular discussion” at the World Trade Organization (WTO) on the TRIPS waiver needs to move to “text-based” negotiations, Ambassador Xolelwa Mlumbi-Peter, South Africa’s Permanent Representative to the WTO said on Tuesday. Her Indian counterpart, Brajendra Navnit, added that opponents of the waiver had been using “delaying tactics” since the beginning of […] Continue reading -> The ‘Silent Pandemic’ of Antimicrobial Resistance – Lessons Learned From COVID-19 30/04/2021 Raisa Santos In the midst of the COVID-19 pandemic, a “silent pandemic” of drug resistance to mutated bacteria, viruses and parasites is gaining ground and requires major government investments in antibiotic research and development (R&D), a group of experts has warned. “People are dying across the world from drug-resistant infections. This is a problem of today, and […] Continue reading -> New Wave Of Appeals For WTO Waiver On IP For COVID Treatments Ahead of TRIPS Council Meeting 27/04/2021 Elaine Ruth Fletcher Nearly 400 members of the European Parliament (MEPs) and of national parliaments from across the European Union issued a joint appeal Tuesday calling for the European Commission to drop its opposition to a proposed WTO waiver on IP related to COVID-19 health technologies for the duration of the pandemic, being co-sponsored by India and South […] Continue reading -> Pharmaceutical Industry Launches Document on IP Principles Amid Push for TRIPS Waiver 26/04/2021 Kerry Cullinan Amid a huge global push for the World Trade Organization (WTO) to waive intellectual property (IP) rights on products related to COVID-19 for the duration of the pandemic, the pharmaceutical industry launched a document on Monday – World IP Day – asserting that a “strong IP system advances public health” . According to the 10-point […] Continue reading -> The ‘Patent Bargain’, Public Good & COVID19 26/04/2021 Priti Patniak/Geneva Health Files As the hotly contested proposal for an IP waiver on COVID-related health products comes up again for debate on Friday, 30 April at the World Trade Organization’s TRIPS Council, legal expert Hyo Yoon Kang looks at the foundations of IP law to challenge “TRIPS waiver” naysayers. Geneva Health Files [GHF]: You have argued that IP […] Continue reading -> ACT-Accelerator Celebrates 1st Anniversary Amid COVID-19 Surge in India 23/04/2021 Kerry Cullinan One of the few silver linings of the COVID-19 pandemic is the unprecedented collaboration of every sector of society to overcome it – best demonstrated by the Access to COVID-19 Tools Accelerator (ACT-Accelerator), which celebrated its first anniversary on Friday. The ACT-Accelerator’s most famous pillar is the vaccine facility, COVAX, which has distributed almost 40 […] Continue reading -> Growing Consensus Emerging At WTO – Strengthen Supply Chain & Tech Transfer To Expand Vaccine Access 15/04/2021 Svĕt Lustig Vijay A growing consensus seems to be emerging out of this week’s high-level WTO meeting that glaring inequities in access to vaccines can be remedied by strengthening supply chains, avoiding export bans across borders, and ensuring that big pharma voluntarily transfers its vaccine technologies to poorer countries so they can produce their own vaccines. “The significant […] Continue reading -> ‘Unexamined Prejudices’: COVID-19 And Patents 15/04/2021 Sir Robin Jacob This past few weeks has seen a flurry of open letters from academics, politicians and NGOs dispatched to British Prime Minister Boris Johnson, US President Joe Biden and other heads of state, urging their governments to support a proposal to the World Trade Organization to for a proposed “waiver” suspending intellectual property (IP) rights, and […] Continue reading -> Posts navigation Older postsNewer posts
Time to End ‘Delaying Tactics’ on TRIPS Waiver, Say India And South Africa Ahead Of Critical WTO Meeting 04/05/2021 Kerry Cullinan CAPE TOWN – The “circular discussion” at the World Trade Organization (WTO) on the TRIPS waiver needs to move to “text-based” negotiations, Ambassador Xolelwa Mlumbi-Peter, South Africa’s Permanent Representative to the WTO said on Tuesday. Her Indian counterpart, Brajendra Navnit, added that opponents of the waiver had been using “delaying tactics” since the beginning of […] Continue reading -> The ‘Silent Pandemic’ of Antimicrobial Resistance – Lessons Learned From COVID-19 30/04/2021 Raisa Santos In the midst of the COVID-19 pandemic, a “silent pandemic” of drug resistance to mutated bacteria, viruses and parasites is gaining ground and requires major government investments in antibiotic research and development (R&D), a group of experts has warned. “People are dying across the world from drug-resistant infections. This is a problem of today, and […] Continue reading -> New Wave Of Appeals For WTO Waiver On IP For COVID Treatments Ahead of TRIPS Council Meeting 27/04/2021 Elaine Ruth Fletcher Nearly 400 members of the European Parliament (MEPs) and of national parliaments from across the European Union issued a joint appeal Tuesday calling for the European Commission to drop its opposition to a proposed WTO waiver on IP related to COVID-19 health technologies for the duration of the pandemic, being co-sponsored by India and South […] Continue reading -> Pharmaceutical Industry Launches Document on IP Principles Amid Push for TRIPS Waiver 26/04/2021 Kerry Cullinan Amid a huge global push for the World Trade Organization (WTO) to waive intellectual property (IP) rights on products related to COVID-19 for the duration of the pandemic, the pharmaceutical industry launched a document on Monday – World IP Day – asserting that a “strong IP system advances public health” . According to the 10-point […] Continue reading -> The ‘Patent Bargain’, Public Good & COVID19 26/04/2021 Priti Patniak/Geneva Health Files As the hotly contested proposal for an IP waiver on COVID-related health products comes up again for debate on Friday, 30 April at the World Trade Organization’s TRIPS Council, legal expert Hyo Yoon Kang looks at the foundations of IP law to challenge “TRIPS waiver” naysayers. Geneva Health Files [GHF]: You have argued that IP […] Continue reading -> ACT-Accelerator Celebrates 1st Anniversary Amid COVID-19 Surge in India 23/04/2021 Kerry Cullinan One of the few silver linings of the COVID-19 pandemic is the unprecedented collaboration of every sector of society to overcome it – best demonstrated by the Access to COVID-19 Tools Accelerator (ACT-Accelerator), which celebrated its first anniversary on Friday. The ACT-Accelerator’s most famous pillar is the vaccine facility, COVAX, which has distributed almost 40 […] Continue reading -> Growing Consensus Emerging At WTO – Strengthen Supply Chain & Tech Transfer To Expand Vaccine Access 15/04/2021 Svĕt Lustig Vijay A growing consensus seems to be emerging out of this week’s high-level WTO meeting that glaring inequities in access to vaccines can be remedied by strengthening supply chains, avoiding export bans across borders, and ensuring that big pharma voluntarily transfers its vaccine technologies to poorer countries so they can produce their own vaccines. “The significant […] Continue reading -> ‘Unexamined Prejudices’: COVID-19 And Patents 15/04/2021 Sir Robin Jacob This past few weeks has seen a flurry of open letters from academics, politicians and NGOs dispatched to British Prime Minister Boris Johnson, US President Joe Biden and other heads of state, urging their governments to support a proposal to the World Trade Organization to for a proposed “waiver” suspending intellectual property (IP) rights, and […] Continue reading -> Posts navigation Older postsNewer posts
The ‘Silent Pandemic’ of Antimicrobial Resistance – Lessons Learned From COVID-19 30/04/2021 Raisa Santos In the midst of the COVID-19 pandemic, a “silent pandemic” of drug resistance to mutated bacteria, viruses and parasites is gaining ground and requires major government investments in antibiotic research and development (R&D), a group of experts has warned. “People are dying across the world from drug-resistant infections. This is a problem of today, and […] Continue reading -> New Wave Of Appeals For WTO Waiver On IP For COVID Treatments Ahead of TRIPS Council Meeting 27/04/2021 Elaine Ruth Fletcher Nearly 400 members of the European Parliament (MEPs) and of national parliaments from across the European Union issued a joint appeal Tuesday calling for the European Commission to drop its opposition to a proposed WTO waiver on IP related to COVID-19 health technologies for the duration of the pandemic, being co-sponsored by India and South […] Continue reading -> Pharmaceutical Industry Launches Document on IP Principles Amid Push for TRIPS Waiver 26/04/2021 Kerry Cullinan Amid a huge global push for the World Trade Organization (WTO) to waive intellectual property (IP) rights on products related to COVID-19 for the duration of the pandemic, the pharmaceutical industry launched a document on Monday – World IP Day – asserting that a “strong IP system advances public health” . According to the 10-point […] Continue reading -> The ‘Patent Bargain’, Public Good & COVID19 26/04/2021 Priti Patniak/Geneva Health Files As the hotly contested proposal for an IP waiver on COVID-related health products comes up again for debate on Friday, 30 April at the World Trade Organization’s TRIPS Council, legal expert Hyo Yoon Kang looks at the foundations of IP law to challenge “TRIPS waiver” naysayers. Geneva Health Files [GHF]: You have argued that IP […] Continue reading -> ACT-Accelerator Celebrates 1st Anniversary Amid COVID-19 Surge in India 23/04/2021 Kerry Cullinan One of the few silver linings of the COVID-19 pandemic is the unprecedented collaboration of every sector of society to overcome it – best demonstrated by the Access to COVID-19 Tools Accelerator (ACT-Accelerator), which celebrated its first anniversary on Friday. The ACT-Accelerator’s most famous pillar is the vaccine facility, COVAX, which has distributed almost 40 […] Continue reading -> Growing Consensus Emerging At WTO – Strengthen Supply Chain & Tech Transfer To Expand Vaccine Access 15/04/2021 Svĕt Lustig Vijay A growing consensus seems to be emerging out of this week’s high-level WTO meeting that glaring inequities in access to vaccines can be remedied by strengthening supply chains, avoiding export bans across borders, and ensuring that big pharma voluntarily transfers its vaccine technologies to poorer countries so they can produce their own vaccines. “The significant […] Continue reading -> ‘Unexamined Prejudices’: COVID-19 And Patents 15/04/2021 Sir Robin Jacob This past few weeks has seen a flurry of open letters from academics, politicians and NGOs dispatched to British Prime Minister Boris Johnson, US President Joe Biden and other heads of state, urging their governments to support a proposal to the World Trade Organization to for a proposed “waiver” suspending intellectual property (IP) rights, and […] Continue reading -> Posts navigation Older postsNewer posts
New Wave Of Appeals For WTO Waiver On IP For COVID Treatments Ahead of TRIPS Council Meeting 27/04/2021 Elaine Ruth Fletcher Nearly 400 members of the European Parliament (MEPs) and of national parliaments from across the European Union issued a joint appeal Tuesday calling for the European Commission to drop its opposition to a proposed WTO waiver on IP related to COVID-19 health technologies for the duration of the pandemic, being co-sponsored by India and South […] Continue reading -> Pharmaceutical Industry Launches Document on IP Principles Amid Push for TRIPS Waiver 26/04/2021 Kerry Cullinan Amid a huge global push for the World Trade Organization (WTO) to waive intellectual property (IP) rights on products related to COVID-19 for the duration of the pandemic, the pharmaceutical industry launched a document on Monday – World IP Day – asserting that a “strong IP system advances public health” . According to the 10-point […] Continue reading -> The ‘Patent Bargain’, Public Good & COVID19 26/04/2021 Priti Patniak/Geneva Health Files As the hotly contested proposal for an IP waiver on COVID-related health products comes up again for debate on Friday, 30 April at the World Trade Organization’s TRIPS Council, legal expert Hyo Yoon Kang looks at the foundations of IP law to challenge “TRIPS waiver” naysayers. Geneva Health Files [GHF]: You have argued that IP […] Continue reading -> ACT-Accelerator Celebrates 1st Anniversary Amid COVID-19 Surge in India 23/04/2021 Kerry Cullinan One of the few silver linings of the COVID-19 pandemic is the unprecedented collaboration of every sector of society to overcome it – best demonstrated by the Access to COVID-19 Tools Accelerator (ACT-Accelerator), which celebrated its first anniversary on Friday. The ACT-Accelerator’s most famous pillar is the vaccine facility, COVAX, which has distributed almost 40 […] Continue reading -> Growing Consensus Emerging At WTO – Strengthen Supply Chain & Tech Transfer To Expand Vaccine Access 15/04/2021 Svĕt Lustig Vijay A growing consensus seems to be emerging out of this week’s high-level WTO meeting that glaring inequities in access to vaccines can be remedied by strengthening supply chains, avoiding export bans across borders, and ensuring that big pharma voluntarily transfers its vaccine technologies to poorer countries so they can produce their own vaccines. “The significant […] Continue reading -> ‘Unexamined Prejudices’: COVID-19 And Patents 15/04/2021 Sir Robin Jacob This past few weeks has seen a flurry of open letters from academics, politicians and NGOs dispatched to British Prime Minister Boris Johnson, US President Joe Biden and other heads of state, urging their governments to support a proposal to the World Trade Organization to for a proposed “waiver” suspending intellectual property (IP) rights, and […] Continue reading -> Posts navigation Older postsNewer posts
Pharmaceutical Industry Launches Document on IP Principles Amid Push for TRIPS Waiver 26/04/2021 Kerry Cullinan Amid a huge global push for the World Trade Organization (WTO) to waive intellectual property (IP) rights on products related to COVID-19 for the duration of the pandemic, the pharmaceutical industry launched a document on Monday – World IP Day – asserting that a “strong IP system advances public health” . According to the 10-point […] Continue reading -> The ‘Patent Bargain’, Public Good & COVID19 26/04/2021 Priti Patniak/Geneva Health Files As the hotly contested proposal for an IP waiver on COVID-related health products comes up again for debate on Friday, 30 April at the World Trade Organization’s TRIPS Council, legal expert Hyo Yoon Kang looks at the foundations of IP law to challenge “TRIPS waiver” naysayers. Geneva Health Files [GHF]: You have argued that IP […] Continue reading -> ACT-Accelerator Celebrates 1st Anniversary Amid COVID-19 Surge in India 23/04/2021 Kerry Cullinan One of the few silver linings of the COVID-19 pandemic is the unprecedented collaboration of every sector of society to overcome it – best demonstrated by the Access to COVID-19 Tools Accelerator (ACT-Accelerator), which celebrated its first anniversary on Friday. The ACT-Accelerator’s most famous pillar is the vaccine facility, COVAX, which has distributed almost 40 […] Continue reading -> Growing Consensus Emerging At WTO – Strengthen Supply Chain & Tech Transfer To Expand Vaccine Access 15/04/2021 Svĕt Lustig Vijay A growing consensus seems to be emerging out of this week’s high-level WTO meeting that glaring inequities in access to vaccines can be remedied by strengthening supply chains, avoiding export bans across borders, and ensuring that big pharma voluntarily transfers its vaccine technologies to poorer countries so they can produce their own vaccines. “The significant […] Continue reading -> ‘Unexamined Prejudices’: COVID-19 And Patents 15/04/2021 Sir Robin Jacob This past few weeks has seen a flurry of open letters from academics, politicians and NGOs dispatched to British Prime Minister Boris Johnson, US President Joe Biden and other heads of state, urging their governments to support a proposal to the World Trade Organization to for a proposed “waiver” suspending intellectual property (IP) rights, and […] Continue reading -> Posts navigation Older postsNewer posts
The ‘Patent Bargain’, Public Good & COVID19 26/04/2021 Priti Patniak/Geneva Health Files As the hotly contested proposal for an IP waiver on COVID-related health products comes up again for debate on Friday, 30 April at the World Trade Organization’s TRIPS Council, legal expert Hyo Yoon Kang looks at the foundations of IP law to challenge “TRIPS waiver” naysayers. Geneva Health Files [GHF]: You have argued that IP […] Continue reading -> ACT-Accelerator Celebrates 1st Anniversary Amid COVID-19 Surge in India 23/04/2021 Kerry Cullinan One of the few silver linings of the COVID-19 pandemic is the unprecedented collaboration of every sector of society to overcome it – best demonstrated by the Access to COVID-19 Tools Accelerator (ACT-Accelerator), which celebrated its first anniversary on Friday. The ACT-Accelerator’s most famous pillar is the vaccine facility, COVAX, which has distributed almost 40 […] Continue reading -> Growing Consensus Emerging At WTO – Strengthen Supply Chain & Tech Transfer To Expand Vaccine Access 15/04/2021 Svĕt Lustig Vijay A growing consensus seems to be emerging out of this week’s high-level WTO meeting that glaring inequities in access to vaccines can be remedied by strengthening supply chains, avoiding export bans across borders, and ensuring that big pharma voluntarily transfers its vaccine technologies to poorer countries so they can produce their own vaccines. “The significant […] Continue reading -> ‘Unexamined Prejudices’: COVID-19 And Patents 15/04/2021 Sir Robin Jacob This past few weeks has seen a flurry of open letters from academics, politicians and NGOs dispatched to British Prime Minister Boris Johnson, US President Joe Biden and other heads of state, urging their governments to support a proposal to the World Trade Organization to for a proposed “waiver” suspending intellectual property (IP) rights, and […] Continue reading -> Posts navigation Older postsNewer posts
ACT-Accelerator Celebrates 1st Anniversary Amid COVID-19 Surge in India 23/04/2021 Kerry Cullinan One of the few silver linings of the COVID-19 pandemic is the unprecedented collaboration of every sector of society to overcome it – best demonstrated by the Access to COVID-19 Tools Accelerator (ACT-Accelerator), which celebrated its first anniversary on Friday. The ACT-Accelerator’s most famous pillar is the vaccine facility, COVAX, which has distributed almost 40 […] Continue reading -> Growing Consensus Emerging At WTO – Strengthen Supply Chain & Tech Transfer To Expand Vaccine Access 15/04/2021 Svĕt Lustig Vijay A growing consensus seems to be emerging out of this week’s high-level WTO meeting that glaring inequities in access to vaccines can be remedied by strengthening supply chains, avoiding export bans across borders, and ensuring that big pharma voluntarily transfers its vaccine technologies to poorer countries so they can produce their own vaccines. “The significant […] Continue reading -> ‘Unexamined Prejudices’: COVID-19 And Patents 15/04/2021 Sir Robin Jacob This past few weeks has seen a flurry of open letters from academics, politicians and NGOs dispatched to British Prime Minister Boris Johnson, US President Joe Biden and other heads of state, urging their governments to support a proposal to the World Trade Organization to for a proposed “waiver” suspending intellectual property (IP) rights, and […] Continue reading -> Posts navigation Older postsNewer posts
Growing Consensus Emerging At WTO – Strengthen Supply Chain & Tech Transfer To Expand Vaccine Access 15/04/2021 Svĕt Lustig Vijay A growing consensus seems to be emerging out of this week’s high-level WTO meeting that glaring inequities in access to vaccines can be remedied by strengthening supply chains, avoiding export bans across borders, and ensuring that big pharma voluntarily transfers its vaccine technologies to poorer countries so they can produce their own vaccines. “The significant […] Continue reading -> ‘Unexamined Prejudices’: COVID-19 And Patents 15/04/2021 Sir Robin Jacob This past few weeks has seen a flurry of open letters from academics, politicians and NGOs dispatched to British Prime Minister Boris Johnson, US President Joe Biden and other heads of state, urging their governments to support a proposal to the World Trade Organization to for a proposed “waiver” suspending intellectual property (IP) rights, and […] Continue reading -> Posts navigation Older postsNewer posts
‘Unexamined Prejudices’: COVID-19 And Patents 15/04/2021 Sir Robin Jacob This past few weeks has seen a flurry of open letters from academics, politicians and NGOs dispatched to British Prime Minister Boris Johnson, US President Joe Biden and other heads of state, urging their governments to support a proposal to the World Trade Organization to for a proposed “waiver” suspending intellectual property (IP) rights, and […] Continue reading -> Posts navigation Older postsNewer posts